Atlas Trials

Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML

Clinical trial NCT05654194 · COMPLETED

Trial details

NCT number
NCT05654194
Sponsor
The First Affiliated Hospital of Soochow University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2022-10-31
Primary completion
2024-09-29
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.